
Aurinia Pharmaceuticals Inc [AUPH] Records 50-Day SMA of $8.48
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Aurinia Pharmaceuticals Inc’s filing revealed that its Director TANG KEVIN acquired Company’s shares for reported $4.54 million on Dec 09
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Aurinia Pharmaceuticals Inc’s recent filing unveils that its Director TANG KEVIN acquired Company’s shares for reported $4.54 million on Dec
Aurinia Pharmaceuticals Inc’s filing revealed that its Director TANG KEVIN acquired Company’s shares for reported $4.54 million on Dec 09
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Aurinia Pharmaceuticals Inc’s filing revealed that its Director TANG KEVIN acquired Company’s shares for reported $4.54 million on Dec 09
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.